{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T22:06:28Z","timestamp":1748469988195},"reference-count":22,"publisher":"VM Media SP. zo.o VM Group SK","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:00:00Z","timestamp":1609545600000},"content-version":"vor","delay-in-days":732,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reports of Practical Oncology &amp; Radiotherapy"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.rpor.2018.10.002","type":"journal-article","created":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T02:48:55Z","timestamp":1542077335000},"page":"56-59","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association between inflammatory bowel disease and uveal melanoma: case report of two young adults and a literature review"],"prefix":"10.5603","volume":"24","author":[{"given":"Salvatore","family":"Cozzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea Slocker","family":"Escarpa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Lorenzo","family":"Parra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina Najjari","family":"Jamal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep Maria Caminal","family":"Mitjana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep Maria Piulats","family":"R.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferran Guedea","family":"Edo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina Gutierrez","family":"Miguelez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3595","reference":[{"issue":"9","key":"10.1016\/j.rpor.2018.10.002_bib0115","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","article-title":"Uveal melanoma: trends in incidence, treatment, and survival","volume":"118","author":"Sing","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.rpor.2018.10.002_bib0120","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rpor.2018.10.002_bib0125","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11894-015-0467-8","article-title":"Monitoring for extra-intestinal cancers in IBD","volume":"17","author":"Sifuentes","year":"2015","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.rpor.2018.10.002_bib0130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/00365521.2014.992041","article-title":"Malignancies in inflammatory bowel disease","volume":"50","author":"UrpoNieminen","year":"2015","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"10.1016\/j.rpor.2018.10.002_bib0135","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3109\/08916934.2013.873414","article-title":"Immune-mediated inflammatory reactions and tumours as skin side effects of inflammatory bowel disease therapy","volume":"47","author":"Marzano","year":"2014","journal-title":"Autoimmunity"},{"key":"10.1016\/j.rpor.2018.10.002_bib0140","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/j.gastro.2012.05.004","article-title":"Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease","volume":"143","author":"Long","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rpor.2018.10.002_bib0145","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1476-4598-12-98","article-title":"Cancer risk in immune-mediated inflammatorydiseases (IMID)","volume":"12","author":"Beyaert","year":"2013","journal-title":"Mol Cancer"},{"key":"10.1016\/j.rpor.2018.10.002_bib0150","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.cgh.2013.04.033","article-title":"Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis","volume":"12","author":"Singh","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.rpor.2018.10.002_bib0155","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.mayocp.2014.08.012","article-title":"Clinical and histologic findings in patients with uveal melanomas after taking tumour necrosis factor-a inhibitors","volume":"89","author":"Damento","year":"2014","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.rpor.2018.10.002_bib0160","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/MOG.0000000000000286","article-title":"Risk of cancer in inflammatory bowel disease: going up, going down, or still the same?","volume":"32","author":"Garg","year":"2016","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.rpor.2018.10.002_bib0165","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1097\/MIB.0000000000001191","article-title":"Risk factors and clinical outcomes in patients with IBD with melanoma","volume":"23811","author":"Nissen","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.rpor.2018.10.002_bib0170","doi-asserted-by":"crossref","first-page":"387014","DOI":"10.1155\/2013\/387014","article-title":"DNA damage in inflammation-related carcinogenesis and cancer stem cells","volume":"2013","author":"Ohnishi","year":"2013","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.rpor.2018.10.002_bib0175","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.gde.2009.11.004","article-title":"Inflammation and oncogenesis: a vicious connection","volume":"20","author":"Grivennikov","year":"2010","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.rpor.2018.10.002_bib0180","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/CCO.0b013e32831bed7e","article-title":"Corrupt policemen: inflammatory cells promote tumor angiogenesis","volume":"21","author":"Zumsteg","year":"2009","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.rpor.2018.10.002_bib0185","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.rpor.2018.10.002_bib0190","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1189\/jlb.0609385","article-title":"Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation","volume":"86","author":"Solinas","year":"2009","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.rpor.2018.10.002_bib0195","doi-asserted-by":"crossref","first-page":"651","DOI":"10.7150\/ijbs.7.651","article-title":"Dual roles of immune cells and their factors in cancer development and progression","volume":"7","author":"Zamarron","year":"2011","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.rpor.2018.10.002_bib0200","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1101\/gad.183434.111","article-title":"NF-\u03baB, the first quarter-century: remarkable progress and outstanding questions","volume":"26","author":"Hayden","year":"2012","journal-title":"Genes Dev"},{"key":"10.1016\/j.rpor.2018.10.002_bib0205","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.2174\/09298673113209990122","article-title":"Clinical and marketed proteasome inhibitors for cancer treatment","volume":"20","author":"Zhang","year":"2013","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.rpor.2018.10.002_bib0210","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cyto.2016.09.013","article-title":"Do tumor necrosis factor inhibitors increase cancer risk in patients with chronic immune-mediated inflammatory disorders?","volume":"101","author":"Chen","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.rpor.2018.10.002_bib0215","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/j.gastro.2012.05.004","article-title":"Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease","volume":"143","author":"Long","year":"2012","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.rpor.2018.10.002_bib0220","doi-asserted-by":"crossref","first-page":"267","DOI":"10.15403\/jgld.2014.1121.233.mrmk","article-title":"Melanoma and non-melanoma skin cancer in inflammatory bowel disease patients following tumour necrosis factor-\u03b1 inhibitor monotherapy and in combination with tiopurines: analysis of the food and drug administration adverse event reporting system","volume":"23","author":"McKenna","year":"2014","journal-title":"J Gastrointestin Liver Dis"}],"container-title":["Reports of Practical Oncology &amp; Radiotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1507136718301457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1507136718301457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T14:15:02Z","timestamp":1613657702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1507136718301457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1507136718301457"],"URL":"https:\/\/doi.org\/10.1016\/j.rpor.2018.10.002","relation":{},"ISSN":["1507-1367"],"issn-type":[{"value":"1507-1367","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between inflammatory bowel disease and uveal melanoma: case report of two young adults and a literature review","name":"articletitle","label":"Article Title"},{"value":"Reports of Practical Oncology & Radiotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpor.2018.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Greater Poland Cancer Centre. Published by Elsevier Sp. z o.o.","name":"copyright","label":"Copyright"}]}}